









市場
/
株式
/
nasdaq-celz
/

Creative Medical Technology Holdings Inc

CELZ

3.510USD

+0.020+0.57%

終値 09/19, 16:00（ET）15分遅れの株価

9.06M時価総額

損失額直近12ヶ月PER



Creative Medical Technology Holdings Inc

3.510

+0.020+0.57%

概要企業名金融分析

分析

詳細情報 Creative Medical Technology Holdings Inc 企業名

Creative Medical Technology Holdings, Inc. is a commercial stage biotechnology company dedicated to the advancement of identifying and translating novel biological therapeutics in the fields of immunotherapy, endocrinology, urology, neurology and orthopedics. The Company conducts substantially all of its commercial operations through its subsidiary, Creative Medical Technologies, Inc. Its products include AlloStem (CELZ-201-DDT) - allogenic human perinatal tissue derived cell program (clinical phase), ImmCelz (CELZ-100) - personalized supercharged immune therapy platform (pre-clinical trials), Type I Diabetes (CELZ-201 CREATE-1) - type I diabetes, Allostemspine Chronic Lower Back Pain (CELZ 201 ADAPT), Alova, CaverStem - erectile dysfunction treatment, FemCelz - female sexual function treatment, StemSpine - regenerative stem cell procedure for the treatment of degenerative disc disease (clinical trials), and OvaStem - stem cell therapy for premature ovarian failure.

企業情報

企業コードCELZ

会社名Creative Medical Technology Holdings Inc

上場日May 01, 2009

最高経営責任者「CEO」Mr. Timothy Warbington

従業員数4

証券種類Ordinary Share

決算期末May 01

本社所在地211 E. Osborn Rd.

都市PHOENIX

証券取引所NASDAQ Capital Market Consolidated

国United States of America

郵便番号85012

電話番号14803992822

ウェブサイトhttps://creativemedicaltechnology.com/

企業コードCELZ

上場日May 01, 2009

最高経営責任者「CEO」Mr. Timothy Warbington

役員一覧

会社名

会社名/ポジション

ポジション

株式保有

変動額

Mr. Timothy Warbington

President, Chief Executive Officer, Director

12.21K

Mr. Donald Dickerson

Chief Financial Officer, Senior Vice President, Director

17.00

Mr. Michael H. Finger

Independent Director

Mr. Bruce S. Urdang, Esq.

Independent Director

Ms. Susan Hegarty Snow

Independent Director

会社名

会社名/ポジション

ポジション

株式保有

変動額

Mr. Timothy Warbington

President, Chief Executive Officer, Director

12.21K

Mr. Donald Dickerson

Chief Financial Officer, Senior Vice President, Director

17.00

Mr. Michael H. Finger

Independent Director

Mr. Bruce S. Urdang, Esq.

Independent Director

Ms. Susan Hegarty Snow

Independent Director

収益内訳

データなし

データなし

事業別

地域別

データなし

株主

更新時刻: Sat, Sep 6

株主統計

種類

株主統計

比率

Creative Medical Health, Inc.

0.88%

Geode Capital Management, L.L.C.

0.81%

The Vanguard Group, Inc.

0.68%

Warbington (Timothy)

0.47%

Citadel Advisors LLC

0.43%

他の

96.72%

株主統計

比率

Creative Medical Health, Inc.

0.88%

Geode Capital Management, L.L.C.

0.81%

The Vanguard Group, Inc.

0.68%

Warbington (Timothy)

0.47%

Citadel Advisors LLC

0.43%

他の

96.72%

種類

株主統計

比率

Investment Advisor

1.43%

Corporation

0.88%

Investment Advisor/Hedge Fund

0.88%

Individual Investor

0.49%

Hedge Fund

0.47%

他の

95.86%

機関投資家保有株

更新時刻: Tue, Jul 1

報告期間

機関投資家数

保有株式数

比率

変動額

2025Q2

242.47K

9.38%

+92.22K

2025Q1

239.16K

9.28%

+93.67K

2024Q4

67.44K

3.86%

-172.00K

2024Q3

114.73K

8.54%

-150.07K

2024Q2

115.50K

8.55%

-269.83K

2024Q1

151.46K

11.09%

-154.43K

2023Q4

64.97K

4.67%

-273.04K

2023Q3

127.49K

15.08%

-223.19K

2023Q2

127.02K

15.07%

-210.98K

2023Q1

140.30K

16.02%

-112.96K

詳細を見る

株主動向

会社名

保有株式数

比率

変動額

変動率

日付

Creative Medical Health, Inc.

22.70K

0.88%

Apr 15, 2025

Geode Capital Management, L.L.C.

18.27K

0.71%

+7.96K

+77.22%

Mar 31, 2025

The Vanguard Group, Inc.

17.63K

0.68%

Mar 31, 2025

Warbington (Timothy)

12.21K

0.47%

Apr 15, 2025

Northern Trust Investments, Inc.

805.00

0.03%

+805.00

Dec 31, 2023

詳細を見る